TMA analysis showed that the overexpression of CDK4 was related to higher clinical stages and higher TNM grades in synovial sarcomas and this correlated with a poorer patient prognosis in various sarcomas, indicating that CDK4 might be necessary for tumor metastasis. This evidence concerns the gene CDK4 and sarcoma.